Yazar "Zengin, N." seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial(Amer Soc Clinical Oncology, 2011) Yalcin, S.; Uslu, R.; Dane, F.; Yilmaz, U.; Zengin, N.; Buyukunal, E.; Buyukberber, S.; Camci, C.; Sencan, O.; Kilickap, S.Öğe The changing pattern of risk factors and disease characteristics of breast cancer in Turkey: A cross-sectional study of a Turkish oncology group (BREASTTURK)(Amer Soc Clinical Oncology, 2011) Akbulut, H.; Altundag, M. K.; Saip, P.; Coskun, H. S.; Camci, C.; Ozkan, M.; Paydas, S.; Zengin, N.; Alco, G.; Aliustaoglu, M.; Basaran, G.; Yamac, D.; Yucel, I.; Goker, E.; Yaman, E.; Isikdogan, A.; Ozisik, Y. Y.; Topuz, E.; Ozdogan, M.; Icli, F.Öğe A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer(Amer Soc Clinical Oncology, 2011) Yalcin, S.; Uslu, R.; Dane, F.; Yilmaz, U.; Zengin, N.; Buyukunal, E.; Buyukberber, S.; Camci, C.; Sencan, O.; Kilickap, S.
